- Home
- CELC vs OTLY Comparison
CELC vs OTLY Comparison
Compare CELC & OTLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- OTLY
- Stock Information
- Founded
- CELC 2011
- OTLY 1994
- Country
- CELC United States
- OTLY Sweden
- Employees
- CELC N/A
- OTLY N/A
- Industry
- CELC Medical Specialities
- OTLY Packaged Foods
- Sector
- CELC Health Care
- OTLY Consumer Staples
- Exchange
- CELC Nasdaq
- OTLY Nasdaq
- Market Cap
- CELC 594.7M
- OTLY 696.2M
- IPO Year
- CELC 2017
- OTLY 2021
- Fundamental
- Price
- CELC $12.66
- OTLY $0.61
- Analyst Decision
- CELC Strong Buy
- OTLY Buy
- Analyst Count
- CELC 6
- OTLY 3
- Target Price
- CELC $29.17
- OTLY $1.27
- AVG Volume (30 Days)
- CELC 257.7K
- OTLY 3.5M
- Earning Date
- CELC 11-14-2024
- OTLY 11-07-2024
- Dividend Yield
- CELC N/A
- OTLY N/A
- EPS Growth
- CELC N/A
- OTLY N/A
- EPS
- CELC N/A
- OTLY N/A
- Revenue
- CELC N/A
- OTLY $813,471,000.00
- Revenue This Year
- CELC N/A
- OTLY $8.55
- Revenue Next Year
- CELC N/A
- OTLY $8.40
- P/E Ratio
- CELC N/A
- OTLY N/A
- Revenue Growth
- CELC N/A
- OTLY 5.06
- 52 Week Low
- CELC $11.51
- OTLY $0.60
- 52 Week High
- CELC $22.19
- OTLY $1.40
- Technical
- Relative Strength Index (RSI)
- CELC 28.22
- OTLY 30.75
- Support Level
- CELC $15.33
- OTLY $0.76
- Resistance Level
- CELC $16.14
- OTLY $0.96
- Average True Range (ATR)
- CELC 0.97
- OTLY 0.06
- MACD
- CELC -0.28
- OTLY -0.02
- Stochastic Oscillator
- CELC 22.85
- OTLY 1.38
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About OTLY Oatly Group AB
Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, and Icecreams, among others. It caters to Sweden, Germany, the United Kingdom, Netherlands, North America, Finland, and Other markets. The company generates revenue from the EMEA, Americas, and Asia regions, with the majority of revenue generated from the EMEA region.